Carolyn McCourt, MD

Gynecologic Oncology, Surgeon

Carolyn McCourt

Appointment Options

Whether you’re seeking a new patient appointment or exploring treatment options and looking for a second opinion, our Siteman care coordinators are ready to assist you.

My Locations

Center for Advanced Medicine

Center for Advanced Medicine

On WashU Medicine Campus
4921 Parkview Place, Saint Louis, MO 63110

Expertise & Training

Video thumbnail for Carolyn McCourt, MD

Watch video on YouTube

Carolyn McCourt, MD

2 mins

Washington University gynecologic oncologist and surgeon Carolyn McCourt, MD, discusses what gynecologic cancer patients can expect from their extended care team at Siteman Cancer Center. Learn more about Dr. McCourt: https://siteman.wustl.edu/doctor/carolyn-mccourt-md/

Learn more about the Gynecologic Oncology Program at Siteman: https://siteman.wustl.edu/treatment/specialized-programs/gynecologic-oncology/

Almost all cervical cancers are caused by the human papillomavirus (HPV). Here's what you need to know about the link between HPV and cervical cancer: https://siteman.wustl.edu/facts-about-hpv-cervical-cancer/

Symptoms of ovarian cancer can be easy to miss. Learn about what signs to look out for: https://siteman.wustl.edu/subtle-signs-of-ovarian-cancer-women-should-look-out-for/

Endometrial cancer is the 4th most common cancer in women in the U.S., but it's highly curable when caught early. Learn more about the risk factors, symptoms and screening: https://siteman.wustl.edu/endometrial-cancer-symptoms/

Clinical Expertise

  • As a member of our ovariancervical and endometrial cancer specialist teams, Dr. McCourt cares for patients diagnosed with these cancers through treatment and recovery. Dr. McCourt has expertise in minimally invasive surgery and integrative care.

Primary Academic Title

Professor of Obstetrics and Gynecology, Division of Gynecologic Oncology, WashU Medicine

Board Certification

  • 2009: American Board of Obstetrics & Gynecology
  • 2011: Subspecialty Certification in Gynecologic Oncology

Training

  • 2001 - 2005: Resident, Obstetrics & Gynecology, WashU Medicine, St. Louis, MO
  • 2005 - 2008: Fellow, Gynecologic Oncology, Brown University, Providence, RI

Education

  • 2001: MD, Creighton University, Omaha, NE

Research & Selected Publications

Research Publications

Ipatasertib in Patients with Tumors with AKT Mutations: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1K
Authors:

McCourt CK, Wei Z, Kalinsky K, one or more additional authors omitted Flaherty KT

Journal & Year:

Clin Cancer Res | 2025

Multiomic Characterization of Pre- and Post-Neoadjuvant Chemotherapy-Treated Ovarian Cancer Reveals Mediators of Tumorigenesis and Chemotherapy Response
Authors:

Valentine MC, Mullen MM, Kotnik EN, one or more additional authors omitted McCourt CK, one or more additional authors omitted Fuh KC

Journal & Year:

Cancer Res | 2025

Phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination-proficient ovarian cancer
Authors:

Schab A, Compadre A, Drexler R, one or more additional authors omitted McCourt C, one or more additional authors omitted Mullen MM

Journal & Year:

J Clin Invest | 2025

Comprehensive Molecular and Genomic Analysis of NCI-MATCH Subprotocol Y: Capivasertib in Patients With an AKT1 E17K-Mutated Tumor
Authors:

McCourt CK, Gross J, Kalinsky K, one or more additional authors omitted Harris LN

Journal & Year:

JCO Precis Oncol | 2025

Overall survival in patients with endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel in the randomized ENGOT-EN6/GOG-3031/RUBY trial
Authors:

Powell MA, Bjørge L, Willmott L, one or more additional authors omitted McCourt C, Mirza MR

Journal & Year:

Ann Oncol | 2024